United Therapeutics | UTHR - Sales Revenues


United Therapeutics reported $832.5M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Amarin USD 49.22M 451K Dec/2025
Ardelyx USD 120.88M 26.41M Jun/2026
Baxter International USD 2.98B 20M Sep/2026
Bayer EUR 10.05B 820M Sep/2026
BioCryst Pharmaceuticals USD 218.25M 188.3M Jun/2026
Biogen USD 2.8B 60M Sep/2026
BioMarin Pharmaceutical USD 1.03B 40M Sep/2026
Emergent BioSolutions USD 276.6M 6.1M Dec/2023
Gilead Sciences USD 8.3B 500M Sep/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
Halozyme Therapeutics USD 492.97M 11.97M Sep/2026
Insmed USD 524.42M 98.93M Sep/2026
Ionis Pharmaceuticals USD 243M 25M Sep/2026
J&J USD 25.4B 89M Sep/2026
Lexicon Pharmaceuticals USD 5.49M 8.69M Dec/2025
Moderna USD 1.31M 98.69M Sep/2026
Pfizer USD 16.6B 1.57B Sep/2026
PTC Therapeutics USD 357.8M 3.2M Sep/2026
Regeneron Pharmaceuticals USD 5.12B 830M Sep/2026
Sangamo BioSciences USD 356K 125K Jun/2024
Sarepta Therapeutics USD 381.4M 19.9M Sep/2026
Teva Pharmaceutical Industries USD 4.37B 8.3B Sep/2026
United Therapeutics USD 832.5M 49.2M Sep/2026
Vertex Pharmaceuticals USD 3.44B 110M Sep/2026